Correction: A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk
Authors:
Katherine J. Kasper; Iswarya Manoharan; Brian Hallam; Charlotte E. Coleman; Sharon L. Koivu; Matthew A. Weir; Johan Delport; John K. McCormick; Michael S. Silverman
Published in the journal:
PLoS ONE 14(9)
Category:
Correction
doi:
https://doi.org/10.1371/journal.pone.0223079
Johan Delport is not included in the author byline. Johan Delport should be listed as the seventh author and affiliated with Department of Medical Microbiology, London Health Sciences Center, London, Canada. The contributions of this author are as follows: Methodology and Validation.
Zdroje
1. Kasper KJ, Manoharan I, Hallam B, Coleman CE, Koivu SL, Weir MA, et al. (2019) A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk. PLoS ONE 14(8): e0219777. doi: 10.1371/journal.pone.0219777 31398210
Článok vyšiel v časopise
PLOS One
2019 Číslo 9
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Úspěšná resuscitativní thorakotomie v přednemocniční neodkladné péči
- Fixní kombinace paracetamol/kodein nabízí synergické analgetické účinky
Najčítanejšie v tomto čísle
- Graviola (Annona muricata) attenuates behavioural alterations and testicular oxidative stress induced by streptozotocin in diabetic rats
- CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
- Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
- Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania